Questions et Réponses

In 2026, the traditional "perimeter" security model (the idea that everything inside a hospital's Wi-Fi is safe) is considered obsolete. Healthcare organizations have shifted to a Zero-Trust Architecture, where no device—whether it’s a high-tech MRI or a simple smart bed—is trusted by default.

Every IoMT device must now prove its identity through digital certificates before it can communicate with the network. If a device like an infusion pump begins to behave strangely (e.g., trying to access a financial server), the system automatically "quarantines" it in real-time. This prevents a single compromised device from becoming an entry point for a hospital-wide ransomware attack.

2026 marks the peak of "Sovereign Health" initiatives, where GCC nations have moved to secure local supply chains for critical wellness products. Saudi Arabia and the UAE are no longer content with importing generic pharmaceuticals and supplements.

The Saudi Food and Drug Authority (SFDA) has streamlined its registration process, resulting in a surge of locally manufactured, halal-certified nutraceuticals. This shift is part of a broader "health security" strategy, ensuring that the region is resilient against global supply chain disruptions while fostering a domestic biotech sector that specializes in "bio-design" and preventive care

The 2026 ingredient landscape is dominated by a few "gold standard" molecules, alongside a rising interest in traditional botanicals.

• Lutein & Zeaxanthin: These remain the largest segment (holding over 33% market share). In 2026, the focus has shifted to "superior absorption" formulas, such as micro-gels and OCUSorb™ technology.

• Anthocyanins (Bilberry & Blueberry): Widely used to relieve eye fatigue and improve night vision. Blueberry anthocyanins were notably approved as a "novel food ingredient" in recent years, boosting innovation.

• Alpha-Lipoic Acid (ALA): This is the fastest-growing ingredient segment in 2026 due to its powerful antioxidant properties that support cellular regeneration in the retina.

• Omega-3 Fatty Acids: Used specifically for "Dry Eye Syndrome," which now affects nearly 46% of urban professionals in China.

Italy has achieved nearly 100% "dematerialization" of prescriptions in 2026. The PMS no longer relies on physical red or white paper slips; instead, it processes the NRE (Numero Ricetta Elettronica).

When a patient provides their NRE and health card, the PMS pulls the prescription directly from the SAC (Sistema di Accoglienza Centrale) or regional repositories (SAR). The system automatically checks the validity of the prescription, the availability of the drug, and calculates the "Ticket" (the patient's co-payment) based on regional rules, which can vary significantly between Lombardy, Lazio, or Sicily.